Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (61-70 of 420) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|April 29, 2009
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureusHelio S Sader, Paul R Rhomberg, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 17, 2009
In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effectsRonald N Jones, Douglas J Biedenbach, Helio S Sader
Antimicrobial Agents and Chemotherapy|June 25, 2008
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
The Journal of Antimicrobial Chemotherapy|December 1, 2010
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance studyRonald N Jones, Rodrigo E Mendes, Helio S Sader
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|February 12, 2014
Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)Robert K Flamm, Helio S Sader, Ronald N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 17, 2021
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020Helio S Sader, Cecilia G Carvalhaes, Dee Shortridge, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 1, 2002
Antimicrobial therapy for community-acquired pneumonia in adultsClovis Arns da Cunha, Helio S Sader, Antonio C Nicodemo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 6, 2014
Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United StatesMariana Castanheira, Gregory Williams, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018Cecilia G Carvalhaes, Dee Shortridge, Helio S Sader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United StatesRonald N Jones, Rodrigo E Mendes, Helio S Sader, et al.
Pageof 42

Showing results (61-70 of 420) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|April 29, 2009
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureusHelio S Sader, Paul R Rhomberg, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 17, 2009
In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effectsRonald N Jones, Douglas J Biedenbach, Helio S Sader
Antimicrobial Agents and Chemotherapy|June 25, 2008
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
The Journal of Antimicrobial Chemotherapy|December 1, 2010
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance studyRonald N Jones, Rodrigo E Mendes, Helio S Sader
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|February 12, 2014
Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)Robert K Flamm, Helio S Sader, Ronald N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 17, 2021
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020Helio S Sader, Cecilia G Carvalhaes, Dee Shortridge, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 1, 2002
Antimicrobial therapy for community-acquired pneumonia in adultsClovis Arns da Cunha, Helio S Sader, Antonio C Nicodemo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 6, 2014
Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United StatesMariana Castanheira, Gregory Williams, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018Cecilia G Carvalhaes, Dee Shortridge, Helio S Sader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United StatesRonald N Jones, Rodrigo E Mendes, Helio S Sader, et al.
Pageof 42